We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.41% | 17.50 | 17.00 | 18.00 | 17.75 | 17.50 | 17.75 | 194,018 | 13:11:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.16 | 15.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/11/2017 19:54 | Wow, that must be the science bit dc. | incanus | |
07/11/2017 18:25 | Rayrac - Why don't you do us all a favour by sharing your woes with BPRG/Meldex and compare it with your humble opinion on the parallels with OPTI. I'm sure it would make for an interesting discussion. Thus far the only success you have is making yourself look ignorant to new science, new niche areas the world over is getting excited about and you seem oblivious to it. As for the peer review...there is some background on it here: The peer review is in a scientific publication (can't remember it but you don't care anyway) which is a subscription service but believe it becomes available online in a few weeks. In the meantime this is a peer reviewed abstract of the study carried out by Reading University presented at ProBiota ( )and an accompanying scientific poster. Note: authors such as Prof Glenn Gibson and Pro John Swann are LEADERS in their field and as leading academics would not be associated with poorly conducted, poorly analysed, or studies with a commercial bias. This abstract was accompanied by a poster which won the best poster competition. The observant PI will note that there is a lag period between the end of a study and the data being reported, because it goes through an independent peer review process BEFORE publication to ensure SCIENTIFIC VALIDITY of methodology, data collection and analysis, and reporting. This process is robust thus given OPTI confidence in the data and is in addition to the peer review process which takes place before publication of any result at scientific conferences. You will always get detractors and commentators who want to blur the science for their own purposes as can be seen with the debate on climate change. It is perfectly natural to be sceptical of new science, especially ahead of commercial process. However, those that do attempt to detract from the bleeding obvious, do so at their own costs, not mine and those that had done their own research and happened upon the same conclusion I have; in that OPTI has been significantly derisked in 2017, but with a mere 5 months of transition from R&D to commercial there remains room for sceptics until they see the money. Fine, no issue with that either, we have our own risk thresholds. However, simply screaming fraud at the top of your lungs in a library for attention then running out the door giggling - try some reasoned debating based on FACTS not childish behaviour. I have the abstract and poster mentioned. Anyone wanting them only need to PM or email me. | elrico | |
07/11/2017 17:54 | Hey rayrac how's Ukog doing? | 1bokke | |
07/11/2017 17:35 | Bioprogress, I can smell it all over this! | rayrac | |
07/11/2017 17:33 | Peer review anyone? Help those less fortunate, or it may look suspicious to newbies! Judi, help! | rayrac | |
07/11/2017 16:23 | Someone still cranking a few out | judijudi | |
07/11/2017 15:56 | Mind you don't trip over the sarcasm..steady as you go. | 1bokke | |
07/11/2017 15:54 | Chris it might help if you explained and demonstrated what research you have done and then others on here could point you in the right direction. I suspect you haven't had any advice yet as people are worried they may have you duplicating your efforts. | 1bokke | |
07/11/2017 15:44 | I agree pglancy. Chris finds it impossible to post without sarcastic comments and arrogance, no place for that on any bb IMO. | moormoney | |
07/11/2017 15:06 | Do you really expect elrico to help after your antics ffs or anyone. | pglancy | |
07/11/2017 14:50 | Just got a tiny bit more..1855 showing as a sell. | loungeact | |
07/11/2017 14:39 | ooopppps wrong thread | zebbo | |
07/11/2017 14:37 | think ill get me some more prized thingys this afternoon | zebbo | |
07/11/2017 14:12 | Slarty - I'll be sure to take my rose tinted to a well known opticians before I go to HRH Friday. :) | elrico | |
07/11/2017 13:45 | Quite funny rodders to be fair and I laugh at myself with you but it doesn't help my research. Anyone? A link to one of these peer reviews? | chrisg11 | |
07/11/2017 13:35 | Chris ...start your messages with "Only me" | onedayrodders | |
07/11/2017 13:33 | Hello Its me again.. Every couple of posts or so it seems someone states that the LPLDL trial has been peer reviewed and I am absolutely sure it has but where can I find these peer reviews? I am sure elrico has one so can someone ask him to post it on here instead of keep repeating the same things on here ad nauseum. I am trying to do some honest research so please link me to at least one peer review so I can read their comments. Thank you to anyone who hasn't filtered me due to my quest for evidence. | chrisg11 | |
07/11/2017 13:16 | Be careful there elrico it be construed you are being negative and we cant have that. lol | slartybartfaster | |
07/11/2017 11:06 | m4rtinu, fair enough bur hopefully the PR push will help that along. | rafboy | |
07/11/2017 10:36 | Elrico - thanks again. Rafboy - I don't think the public are necessarily stupid, but sometimes they are not interested in detail; important though it might be. Anyway, regarding SP: it seems to have settled in 70s quite comfortably. On a lighter note, I did wonder if the sells this am were people selling a few shares to buy their supplies of probiotics :) | m4rtinu | |
07/11/2017 10:25 | Martin - As I understand it, corporates are approaching OPTI because their products/IP has strong scientific backing. The BOD have wheels in motion to further validate this with larger human studies - see the new SACCO deal announced. There will also be a PR push to make the public aware of the science backing. The recent FDA approval is a key step in this direction. Also, the growing public awareness is also key. Christina and Max gave us an insight into how the company are thinking in terms of markets and public perception and how they will approach this and the market specific sectors. | elrico | |
07/11/2017 10:15 | How can it? Once the public is made aware of the science behind the products and I'm sure they will, then the public are not stupid. Would you buy something that the company says will work or would you buy it from the company that not only says it works but is backed by science and can be proven to be effective? I think much will depend on the media campaign that goes alongside the product launch. | rafboy | |
07/11/2017 10:04 | Thanks, I will find a more comfortable chair and read! Just a follow up. I did express a worry before about possible competitors with lesser products/ research not done. In your words Elrico " ... plenty of competition, but much of it is NOT science backed or peer reviewed". Will this cloud the public's impressions? And might this adversely affect OPTI, who are playing by the rules of science. I hope not. | m4rtinu |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions